BAXTER INTERNATIONAL INC's gross profit margin for the first quarter of its fiscal year 2016 has decreased when compared to the same period a year ago. Even though sales decreased, the net income has increased, representing an increase to the bottom line.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY16||Q1 FY15|
|Net Sales ($mil)||2375.0||3764.0|
|Net Income ($mil)||3380.0||430.0|
|Balance Sheet||Q1 FY16||Q1 FY15|
|Cash & Equiv. ($mil)||0.0||2530.0|
|Total Assets ($mil)||0.0||24861.0|
|Total Debt ($mil)||0.0||10005.0|
|Profitability||Q1 FY16||Q1 FY15|
|Gross Profit Margin||40.63||47.69|
|Return on Assets||0.0||9.53|
|Return on Equity||0.0||5.09|
|Debt||Q1 FY16||Q1 FY15|
|Share Data||Q1 FY16||Q1 FY15|
|Shares outstanding (mil)||547.66||543.85|
|Div / share||0.12||0.52|
|Book value / share||0.0||13.35|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||5573515.0||4438911.0|
BUY. BAXTER INTERNATIONAL INC's P/E ratio indicates a significant discount compared to an average of 49.25 for the Health Care Equipment & Supplies industry and a significant discount compared to the S&P 500 average of 24.18. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, BAXTER INTERNATIONAL INC proves to trade at a discount to investment alternatives within the industry.
|BAX 7.24||Peers 49.25||BAX NA||Peers 29.94|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
BAX is trading at a significant discount to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|BAX 23.94||Peers 23.48||BAX 0.06||Peers 0.97|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
BAX is trading at a premium to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
BAX trades at a significant discount to its peers.
|BAX NA||Peers 4.79||BAX 819.69||Peers 29.84|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
Ratio not available.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
BAX is expected to have an earnings growth rate that significantly exceeds its peers.
|BAX 2.81||Peers 4.64||BAX -19.34||Peers 19.87|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
BAX is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
BAX significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.